IP Library Granted Patent US 7,919,257
Granted Patent B2
US 7,919,257 · App. 11/292,414 · Granted Apr 5, 2011

Method for selecting a single cell expressing a heterogeneous combination of antibodies

Assignee: Merus Biopharmaceuticals, B.V.i.o.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,919,257
App. No.
11/292,414
Granted
Apr 5, 2011
Kind
B2
Abstract

The present invention provides combinations of specific binding proteins, such as immunoglobulins, that are designed to be true combinations, essentially all components of the combination being functional and compatible with each other. The invention further provides a method for producing a composition comprising at least two different proteinaceous molecules comprising paired variable regions, the at least two proteinaceous molecules having different binding specificities, comprising paired variable regions, at least two proteinaceous molecules having different binding specificities, comprising contacting at least three different variable regions under conditions allowing for pairing of variable regions and harvesting essentially all proteinaceous molecules having binding specificities resulting from the pairing.

Claims (25)

1. A method for selecting a single recombinant cell that expresses a heterogeneous combination of monospecific and bispecific antibodies, or antibody fragments thereof, wherein the monospecific and bispecific antibodies, or antibody fragments thereof, are human, humanized, or deimmunized, and wherein the heterogeneous combination has specific affinity for two target epitopes, said method comprising:

carrying out a process for producing the heterogeneous combination; the process comprising

providing three different variable regions consisting of two heavy chain regions and one light chain variable region in recombinant cells, wherein antigen binding parts of the variable regions originate from an antibody from a single species and wherein one variable region is able to functionally pair with more than one other variable region, and under conditions allowing for pairing of variable regions and secretion of the paired regions from the recombinant cells resulting in the production of said heterogeneous combination, and

providing two target epitopes,

selecting a single recombinant cell from said recombinant cells that produces a heterogeneous combination that binds the two target epitopes, and

co-purifying the heterogeneous combination therefrom utilizing a shared feature of each of the monospecific and bispecific antibodies, or antibody fragments thereof.

2. The method according to claim 1 , wherein said two target epitopes are associated with a disease and/or disorder.

3. The method according to claim 2 , further comprising:

subjecting a heterogeneous combination to a biological assay indicative of an effect of the combination on the disease and/or disorder.

4. The method according to claim 1 , wherein the one variable region able to functionally pair with more than one other variable region does not significantly contribute to the resulting binding specificity of the resulting paired regions.

5. The method according to claim 1 , wherein each variable region can only pair with one other variable region.

6. The method according to claim 1 , wherein two of the three variable regions are part of one single chain Fv.

7. The method according to claim 1 , wherein the expression of two of the variable regions is under the direction of different control elements.

8. The method according to claim 7 , wherein the different control elements lead to differential expression.

9. The method according to claim 8 , wherein the differential expression is different in levels of expression and/or time of expression.

10. The method according to claim 1 , wherein the combination comprises two monospecific antibodies produced in the single recombinant cell.

11. The method according to claim 1 , further comprising

producing an expression system comprising nucleic acid sequences encoding variable regions; said producing comprising:

synthesizing nucleic acid sequences encoding variable regions,

expressing said nucleic acid sequences and allowing the expression products to pair, and

selecting nucleic acid sequences encoding variable regions having desired pairing behavior, so as to produce nucleic acid sequences encoding variable regions.

12. A method for producing a heterogeneous combination of monospecific and bispecific antibodies, or antibody fragments thereof, the method comprising:

carrying out a selection method according to claim 1 , and

allowing the selected cell to express the heterogeneous combination of monospecific and bispecific antibodies, or antibody fragments thereof, resulting in the production of said heterogeneous combination.

13. The method according to claim 1 , wherein the shared feature is an Fc region.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 041675 FRAME: 0842. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE ADDRESS. Recorded Apr 4, 2017
From: MERUS N.V.
To: MERUS N.V.
Reel/Frame 042322/0304 →
CHANGE OF ADDRESS Recorded Feb 10, 2017
From: MERUS N.V.
To: MERUS N.V.
Reel/Frame 041675/0842 →
CHANGE OF NAME Recorded Jun 1, 2016
From: MERUS B.V.
To: MERUS N.V.
Reel/Frame 038853/0599 →
CHANGE OF NAME Recorded Jul 8, 2011
From: MERUS BIOPHARMACEUTICALS, B.V. I.O.
To: MERUS B.V.
Reel/Frame 026619/0391 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2006
From: HOOGENBOOM, HENDRICUS RENERUS JACOBUS MATTHEUS; LOGTENBERG, TON
To: MERUS BIOPHARMACEUTICALS, B.V.I.O.
Reel/Frame 017729/0594 →
Priority Claims (1)
EP 03076671 · May 30, 2003 · regional
Continuity (2)
Continuation PCTNL2004000386 · May 28, 2004
Related Publication 20060160184A1 · Jul 20, 2006